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Electromechanical mapping of the left ventricle  
for stem cell injection in a patient with  
permanent atrial fibrillation
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Stem cell therapies for improvement of the ischaemic myocardium are an emerging and promising therapeutic option. 
Three-dimensional NOGA mapping allows simultaneous registration of left ventricle (LV) mechanical and electrical activ-
ity, enabling assessment of myocardial viability and targeted cell delivery. However, LV mapping in patients during atrial 
fibrillation (AF) is considered time consuming and difficult. A 77-year-old man was admitted to our centre presenting with 
refractory angina. His risk factors included hypertension, hyperlipidaemia, and advanced chronic renal failure, he also 
had a history of permanent AF. In the past he had undergone coronary artery bypass grafting twice: in 1985 and 2002, 
he had also suffered from a non-ST-elevation myocardial infarction treated with percutaneous coronary intervention with 
a drug eluting stent implantation in 2010. At the moment of admission, he was in CCS class III despite optimal medical 
treatment. The patient had previously been disqualified from any further revascularisation by the Heart Team. Echocar-
diography revealed a mild impairment of the LV ejection fraction (LVEF 45%), with hypokinesia of the intraventricular 
septum and inferior wall. Single-photon emission computed tomography (SPECT) showed reversible perfusion defects 
in the anterolateral region. AF with short QRS duration (80 ms) and relatively good rate control (80 bpm) was observed 
in an electrocardiogram. The patient was enrolled to the REGENT (autologous CD133+ cells vs. placebo, double-blind, 
placebo-controlled RCT) trial to undergo targeted transendocardial treatment. We used a NOGA-XP System to perform 
electromechanical mapping and direct transendocardial cell injection. A diagnostic NOGA STAR catheter was placed in 
the LV under fluoroscopic guidance, and LV electromechanical mapping was performed. Completing the data necessary 
to build the map and localise the target area took about 60 min. The regions of hibernating myocardium defined by 
preserved electrical and decreased mechanical activity correlated with reversible perfusion defects detected by SPECT. 
Time volume graphs showed evident dyssynchrony of the hibernating areas (Fig. 1). Following the standardised NOGA 
injection criteria, twelve 0.2 mL injections of autologous CD133+ bone marrow stem cells or placebo (procedure 
double-blinded) were placed into the anterolateral viable area (> 5 mV unipolar) with low wall movement (< 6% LLS) 
(Fig. 2). Only limited premature ventricular contractions were detectable at injections, which can probably be explained 
by a reduced time window for excitation after the electrical refractory period. Total injection time was 20 min. Mapping 
and injection were completed within 80 min despite permanent AF. No raise in creatinine levels, pericardial effusion, and 
no local complications were observed in the days following the procedure. To conclude, despite technical difficulties due 
to irregular rhythm, electromechanical mapping on AF is feasible. Completing the procedure in patients with AF and good 
heart rate control does not have to be more time consuming than in patients on sinus rhythm. Additionally, time volume 
graphs display differences in wall movement of hibernating and normal tissue even during 
AF, providing us with additional information on segmental ventricular contraction synchrony.
Figure 2. Injection sites of 
bone marrow stem cells/pla-
cebo into the anterolateral 
wallFigure 1. Time volume graphs of the normal (pink coded) and hibernating (red coded) areas
